In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

[Q]: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Post Office Relocation Act of
1997''.

SEC. 2. GUIDELINES FOR RENOVATION, RELOCATION, CLOSING, OR
CONSOLIDATION OF POST OFFICES.

Section 404(b) of title 39, United States Code, is amended to read
as follows--
''(b)(1) The Postal Service, prior to making a determination under
subsection (a)(3) of this section as to the necessity for the
renovation, relocation, closing, or consolidation of any post office,
shall provide adequate notice of its intention to renovate, relocate,
close, or consolidate such post office at least 60 days prior to the
proposed date of such renovation, relocation, closing, or consolidation
to persons served by such post office.
''(2) Such notification shall be made in writing and shall be hand
delivered or delivered by mail to persons served by such post office,
and shall be published in one or more newspapers of general circulation
within the zip codes served by such post office. Such notification
shall include--
''(A) an identification of the renovation, relocation,
closing, or consolidation;
''(B) a summary of the reasons for the renovation,
relocation, closing, or consolidation; and
''(C) the proposed date for the renovation, relocation,
renovation, closing, or consolidation.
''(3) Any person served by the post office may offer an alternative
renovation, relocation, consolidation, or closing proposal within the
60 day notice period. The Postal Service shall deliver a response in
writing by hand delivery or certified mail to the person making the
proposal. In a case in which the Postal Service rejects a bona fide
proposal, the Postal Service shall state in writing the reasons for the
rejection.
''(4) At the end of the 60 day notice period, the Postal Service
shall make a determination under subsection (a)(3). Prior to making a
final determination, the Postal Service shall conduct a hearing, and
persons served by the post office may present oral or written testimony
with respect to the renovation, relocation, closing, or consolidation
of such post office. The Postal Service, in making a determination as
to whether or not to renovate, relocate, close, or consolidate a post
office shall consider--
''(A) the extent to which such post office is part of a
core downtown business area;
''(B) the effect of such renovation, relocation, closing,
or consolidation on the community served by such post office;
''(C) whether the community served by such post office
opposes a renovation, relocation, closing, or consolidation;
''(D) the effect of such renovation, relocation, closing,
or consolidation on employees of the Postal Service employed at
such office;
''(E) whether such renovation, relocation, closing, or
consolidation is consistent with the policy of the Government,
as stated in section 101(b) of this title, that the Postal
Service shall provide a maximum degree of effective and regular
postal services to rural areas, communities, and small towns
where post offices are not self sustaining;
''(F) the quantified long-term economic saving to the
Postal Service resulting from such renovation, relocation,
closing, or consolidation;
''(G) whether postal officials engaged in negotiations with
persons served by the post office concerning the proposed
renovation, relocation, closing, or consolidation;
''(H) whether management of the post office contributed to
a desire to relocate;
''(I) the adequacy of the existing post office, and whether
all reasonable alternatives have been explored; and
''(J) such other factors as the Postal Service determines
are necessary.
''(5) Any determination of the Postal Service to renovate,
relocate, close, or consolidate a post office shall be in writing and
shall include the findings of the Postal Service with respect to the
considerations required to be made under paragraph (4) of this
subsection. Such determination and findings shall be made available to
persons served by such post office.
''(6) The Postal Service shall take no action to renovate,
relocate, close, or consolidate a post office until 60 days after its
written determination is made available to persons served by such post
office.
''(7) A determination of the Postal Service to renovate, relocate,
close, or consolidate any post office may be appealed by any person
served by such post office to the Postal Rate Commission within 30 days
after such determination is made available to such person under
paragraph (5). The Commission shall review such determination on the
basis of the record before the Postal Service in the making of such
determination. The Commission shall make a determination based upon
such review no later than 120 days after receiving any appeal under
this paragraph. The commission shall set aside any determination,
findings, and conclusions found to be--
''(A) arbitrary, capricious, an abuse of discretion, or
otherwise not in accordance with the law;
''(B) without observance of procedure required by law; or
''(C) unsupported by substantial evidence on the record.
The Commission may affirm the determination of the Postal Service or
order that the entire matter be returned for further consideration, but
the Commission may not modify the determination of the Postal Service.
The Commission may suspend the effectiveness of the determination of
the Postal Service until the final disposition of the appeal. The
provisions of section 556, section 557, and chapter 7 of title 5 shall
not apply to any review carried out by the Commission under this
paragraph.
''(8) In a case in which a community has procedures to address the
renovation, relocation, closing, or consolidation of buildings in the
community, and the public participation requirements of such procedures
are more stringent than those provided in this subsection, the Postal
Service shall follow such procedures and disregard the procedures
established in this subsection.
''(9) The Postal Service, in making a determination to renovate,
relocate, close, or consolidate any post office, shall comply with any
zoning, planning, or land use regulations, or building codes applicable
to State or local public entities, including the zoning authority, of
the local jurisdiction.''.

SEC. 3. POLICY STATEMENT.

Section 101(g) of title 39, United States Code, is amended by
adding at the end the following: ''The Postal Service shall also
consider the effect a new postal facility may have on the community
served by the prior facility.''.
[A]: Post Office Relocation Act of 1997 - Modifies Federal postal provisions to require a 60-day notice before the renovation, relocation, closing, or consolidation (currently, the closing or consolidation) of a post office. Requires such notice to be: (1) hand delivered or delivered by mail; and (2) published in one or more newspapers of general circulation within the zip codes served by such post office.
Sets forth provisions which: (1) allow any person served by the post office to offer an alternative renovation, relocation, consolidation, or closing proposal within such 60-day period; and (2) require the Postal Service to conduct a hearing to allow the individual to present oral or written testimony.
Revises the factors to be considered in deciding whether or not to renovate, relocate, close, or consolidate a post office to include: (1) the extent to which the post office is part of a core downtown business area; (2) the sentiment of the community; (3) whether postal officials negotiated with persons served; (4) whether management of the post office contributed to a desire to relocate; and (5) the adequacy of the existing post office.
Requires the Postal Service to follow a community's public participation procedures to address the renovation, relocation, closing, or consolidation of buildings in the community if participation requirements of such procedures are more stringent than those provided in this Act.
Requires the Postal Service, in making a determination to renovate, relocate, close, or consolidate any post office, to comply with any zoning, planning, or land use regulations or building codes applicable to State or local public entities, including the zoning authority of the local jurisdiction.
Includes within the Postal Service policy with respect to planning and building new postal facilities that the Service consider the effect a new facility may have on the community.

[Q]: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Preservation of Antibiotics for
Medical Treatment Act of 2011''.

SEC. 2. FINDINGS.

The Congress finds the following:
(1) In January 2001, a Federal interagency task force--
(A) released an action plan to address the
continuing decline in effectiveness of antibiotics
against common bacterial infections, referred to as
antibiotic resistance;
(B) determined that antibiotic resistance is a
growing menace to all people and poses a serious threat
to public health; and
(C) cautioned that if current trends continue,
treatments for common infections will become
increasingly limited and expensive, and, in some cases,
nonexistent.
(2) Antibiotic resistance, resulting in a reduced number of
effective antibiotics, may significantly impair the ability of
the United States to respond to terrorist attacks involving
bacterial infections or a large influx of hospitalized
patients.
(3)(A) Any overuse or misuse of antibiotics contributes to
the spread of antibiotic resistance, whether in human medicine
or in agriculture.
(B) Recognizing the public health threat caused by
antibiotic resistance, Congress took several steps to curb
antibiotic overuse in human medicine through amendments to the
Public Health Service Act (42 U.S.C. 201 et seq.) made by
section 102 of the Public Health Threats and Emergencies Act
(Public Law 106-505, title I; 114 Stat. 2315), but has not yet
addressed antibiotic overuse in agriculture.
(4) In a March 2003 report, the National Academy of
Sciences stated that--
(A) a decrease in antimicrobial use in human
medicine alone will have little effect on the current
situation; and
(B) substantial efforts must be made to decrease
inappropriate overuse in animals and agriculture.
(5) In 2010, the FDA determined that--
(A) 13.1 million kilograms of antibacterial drugs
were sold for use on food animals in the United States
in 2009;
(B) 3.3 million kilograms of antibacterial drugs
were used for human health in 2009; and
(C) therefore, 80 percent of antibacterial drugs
disseminated in the United States in 2009 were sold for
use on food animals, rather than being used for human
health.
(6)(A) Large-scale, voluntary surveys by the Department of
Agriculture's Animal and Plant Health Inspection Service in
1999, 2001, and 2006 revealed that--
(i) 84 percent of grower-finisher swine farms, 83
percent of cattle feedlots, and 84 percent of sheep
farms administer antimicrobials in the feed or water
for health or growth promotion reasons; and
(ii) many of the antimicrobials identified are
identical or closely related to drugs used in human
medicine, including tetracyclines, macrolides,
Bacitracin, penicillins, and sulfonamides; and
(B) these drugs are used in people to treat serious
diseases such as pneumonia, scarlet fever, rheumatic fever,
venereal disease, skin infections, and even pandemics like
malaria and plague, as well as bioterrorism agents like
smallpox and anthrax.
(7) Many scientific studies confirm that the nontherapeutic
use of antibiotics in agricultural animals contributes to the
development of antibiotic-resistant bacterial infections in
people.
(8) The periodical entitled ''Clinical Infectious
Diseases'' published a report in June 2002, that--
(A) was based on a 2-year review by experts in
human and veterinary medicine, public health,
microbiology, biostatistics, and risk analysis, of more
than 500 scientific studies on the human health impacts
of antimicrobial use in agriculture; and
(B) recommended that antimicrobial agents should no
longer be used in agriculture in the absence of
disease, but should be limited to therapy for diseased
individual animals and prophylaxis when disease is
documented in a herd or flock.
(9) The United States Geological Survey reported in March
2002 that--
(A) antibiotics were present in 48 percent of the
streams tested nationwide; and
(B) almost half of the tested streams were
downstream from agricultural operations.
(10) An April 1999 study by the General Accounting Office
concluded that resistant strains of 3 microorganisms that cause
food-borne illness or disease in humans (Salmonella,
Campylobacter, and E. coli) are linked to the use of
antibiotics in animals.
(11) Epidemiological research has shown that resistant
Salmonella and Campylobacter infections are associated with
increased numbers of ill patients and bloodstream infections,
and increased death.
(12) In 2010, the peer-reviewed journal Molecular Cell
published a study demonstrating that low-dosage use of
antibiotics causes a dramatic increase in genetic mutation,
raising new concerns about the agricultural practice of using
low-dosage antibiotics in order to stimulate growth promotion
and routinely prevent disease in unhealthy conditions.
(13)(A) In January 2003, Consumer Reports published test
results on poultry products bought in grocery stores nationwide
showing disturbingly high levels of Campylobacter and
Salmonella bacteria that were resistant to the antibiotics used
to treat food-borne illnesses.
(B) The Food and Drug Administration's National
Antimicrobial Resistance Monitoring System routinely finds that
retail meat products are contaminated with bacteria (including
the foodborne pathogens Campylobacter and Salmonella) that are
resistant to antibiotics important in human medicine.
(C) In December 2007, the USDA issued a fact sheet on the
recently recognized link between antimicrobial drug use in
animals and Methicillin Resistant Staphylococcus Aureas (MRSA)
infections in humans.
(14) In October 2001, the New England Journal of Medicine
published an editorial urging a ban on nontherapeutic use of
medically important antibiotics in animals.
(15)(A) In 1998, the National Academy of Sciences noted
that antibiotic-resistant bacteria generate a minimum of
$4,000,000,000 to $5,000,000,000 in costs to United States
society and individuals yearly.
(B) In 2009, Cook County Hospital and the Alliance for
Prudent Use of Antibiotics estimated that the total health care
cost of antibiotic resistant infections in the United States
was between $16,600,000,000 and $26,000,000,000 annually.
(16) The American Medical Association, the American Public
Health Association, the National Association of County and City
Health Officials, and the National Campaign for Sustainable
Agriculture are among the more than 300 organizations
representing health, consumer, agricultural, environmental,
humane, and other interests that have supported enactment of
legislation to phase out nontherapeutic use in farm animals of
medically important antibiotics.
(17) In 2010, the Danish Veterinary and Food Administration
testified that the Danish ban of the non-therapeutic use of
antibiotics in food animal production resulted in a marked
reduction in antimicrobial resistance in multiple bacterial
species, including Campylobacter and Enterococci.
(18) In 2009, the Congressional Research Service concluded
that restrictions overseas on the use of antimicrobial drugs in
the production of livestock could impact U.S. export markets
for livestock and poultry.
(19) The Federal Food, Drug, and Cosmetic Act (21 U.S.C.
301 et seq.)--
(A) requires that all drugs be shown to be safe
before the drugs are approved; and
(B) places the burden on manufacturers to account
for health consequences and prove safety.
(20)(A) The Food and Drug Administration recently modified
the drug approval process for antibiotics to recognize the
development of resistant bacteria as an important aspect of
safety, but most antibiotics currently used in animal
production systems for nontherapeutic purposes were approved
before the Food and Drug Administration began considering
resistance during the drug-approval process.
(B) The Food and Drug Administration has not established a
schedule for reviewing those existing approvals.
(21) Certain non-routine uses of antibiotics in animal
agriculture are legitimate to prevent animal disease.
(22) An April 2004 study by the General Accounting Office--
(A) concluded that Federal agencies do not collect
the critical data on antibiotic use in animals that
they need to support research on human health risks;
and
(B) recommends that the Department of Agriculture
and the Department of Health and Human Services develop
and implement a plan to collect data on antibiotic use
in animals.

SEC. 3. PURPOSE.

The purpose of this Act is to preserve the effectiveness of
medically important antibiotics used in the treatment of human and
animal diseases by reviewing the safety of certain antibiotics for
nontherapeutic purposes in food-producing animals.

SEC. 4. PROOF OF SAFETY OF CRITICAL ANTIMICROBIAL ANIMAL DRUGS.

(a) Definitions.--Section 201 of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 321) is amended by adding at the end the
following:
''(ss) Critical Antimicrobial Animal Drug.--The term 'critical
antimicrobial animal drug' means a drug that--
''(1) is intended for use in food-producing animals; and
''(2) is composed wholly or partly of--
''(A) any kind of penicillin, tetracycline,
macrolide, lincosamide, streptogramin, aminoglycoside,
or sulfonamide; or
''(B) any other drug or derivative of a drug that
is used in humans or intended for use in humans to
treat or prevent disease or infection caused by
microorganisms.
''(tt) Nontherapeutic Use.--The term 'nontherapeutic use', with
respect to a critical antimicrobial animal drug, means any use of the
drug as a feed or water additive for an animal in the absence of any
clinical sign of disease in the animal for growth promotion, feed
efficiency, weight gain, routine disease prevention, or other routine
purpose.''.
(b) Applications Pending or Submitted After Enactment.--Section
512(d)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
360b(d)(1)) is amended--
(1) in the first sentence--
(A) in subparagraph (H), by striking ''or'' at the
end;
(B) in subparagraph (I), by inserting ''or'' at the
end; and
(C) by inserting after subparagraph (I) the
following:
''(J) with respect to a critical antimicrobial
animal drug or a drug of the same chemical class as a
critical antimicrobial animal drug, the applicant has
failed to demonstrate that there is a reasonable
certainty of no harm to human health due to the
development of antimicrobial resistance that is
attributable, in whole or in part, to the
nontherapeutic use of the drug; or''; and
(2) in the second sentence, by striking ''(A) through (I)''
and inserting ''(A) through (J)''.
(c) Phased Elimination of Nontherapeutic Use in Animals of Critical
Antimicrobial Animal Drugs Important for Human Health.--Section 512 of
the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b) is amended by
adding at the end the following:
''(q) Phased Elimination of Nontherapeutic Use in Animals of
Critical Antimicrobial Animal Drugs Important for Human Health.--
''(1) Applicability.--This subsection applies to the
nontherapeutic use in a food-producing animal of a drug--
''(A)(i) that is a critical antimicrobial animal
drug; or
''(ii) that is of the same chemical class as a
critical antimicrobial animal drug; and
''(B)(i) for which there is in effect an approval
of an application or an exemption under subsection (b),
(i), or (j) of section 505; or
''(ii) that is otherwise marketed for use.
''(2) Withdrawal.--The Secretary shall withdraw the
approval of a nontherapeutic use in food-producing animals
described in paragraph (1) on the date that is 2 years after
the date of enactment of this subsection unless--
''(A) before the date that is 2 years after the
date of the enactment of this subsection, the Secretary
makes a final written determination that the holder of
the approved application has demonstrated that there is
a reasonable certainty of no harm to human health due
to the development of antimicrobial resistance that is
attributable in whole or in part to the nontherapeutic
use of the drug; or
''(B) before the date specified in subparagraph
(A), the Secretary makes a final written determination
under this subsection, with respect to a risk analysis
of the drug conducted by the Secretary and other
relevant information, that there is a reasonable
certainty of no harm to human health due to the
development of antimicrobial resistance that is
attributable in whole or in part to the nontherapeutic
use of the drug.
''(3) Exemptions.--Except as provided in paragraph (5), if
the Secretary grants an exemption under section 505(i) for a
drug that is a critical antimicrobial animal drug, the
Secretary shall rescind each approval of a nontherapeutic use
in a food-producing animal of the critical antimicrobial animal
drug, or of a drug in the same chemical class as the critical
antimicrobial animal drug, as of the date that is 2 years after
the date on which the Secretary grants the exemption.
''(4) Approvals.--Except as provided in paragraph (5), if
an application for a drug that is a critical antimicrobial
animal drug is submitted to the Secretary under section 505(b),
the Secretary shall rescind each approval of a nontherapeutic
use in a food-producing animal of the critical antimicrobial
animal drug, or of a drug in the same chemical class as the
critical antimicrobial animal drug, as of the date that is 2
years after the date on which the application is submitted to
the Secretary.
''(5) Exception.--Paragraph (3) or (4), as the case may be,
shall not apply if--
''(A) before the date on which approval would be
rescinded under that paragraph, the Secretary makes a
final written determination that the holder of the
application for the approved nontherapeutic use has
demonstrated that there is a reasonable certainty of no
harm to human health due to the development of
antimicrobial resistance that is attributable in whole
or in part to the nontherapeutic use in the food-
producing animal of the critical antimicrobial animal
drug; or
''(B) before the date specified in subparagraph
(A), the Secretary makes a final written determination
under this subsection, with respect to a risk analysis
of the critical antimicrobial animal drug conducted by
the Secretary and any other relevant information, that
there is a reasonable certainty of no harm to human
health due to the development of antimicrobial
resistance that is attributable in whole or in part to
the nontherapeutic use of the drug.''.

SEC. 5. COMMITTEE HEARINGS ON IMPLEMENTATION.

(a) In General.--The Committee on Energy and Commerce of the House
of Representatives and the Committee on Energy of the Senate shall each
hold a hearing on the implementation by the Commissioner of Food and
Drugs of section 512(q) of the Federal Food, Drug, and Cosmetic Act, as
added by section 4 of this Act.
(b) Exercise of Rulemaking Authority.--Subsection (a) is enacted--
(1) as an exercise of the rulemaking power of the House of
Representatives and Senate, and, as such, they shall be
considered as part of the rules of the House or Senate (as the
case may be), and such rules shall supersede any other rule of
the House or Senate only to the extent that rule is
inconsistent therewith; and
(2) with full recognition of the constitutional right of
either House to change such rules (so far as relating to the
procedure in such House) at any time, in the same manner, and
to the same extent as in the case of any other rule of the
House or Senate.
[A]: Preservation of Antibiotics for Medical Treatment Act of 2011 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services (HHS) to deny an application for a new animal drug that is a critical antimicrobial animal drug unless the applicant demonstrates that there is a reasonably certainty of no harm to human health due to the development of antimicrobial resistance attributable to the nontherapeutic use of the drug. Defines "critical antimicrobial animal drug" as a drug intended for use in food-producing animals that contains specified antibiotics or other drugs used in humans to treat or prevent disease or infection caused by microorganisms.

Requires the Secretary to withdraw approval of a nontherapeutic use of such drugs in food-producing animals two years after the date of enactment of this Act unless certain safety requirements are met. Directs specified congressional committees to hold hearings on the implementation of such a withdrawal of approval.

[Q]: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Iran Human Rights Sanctions Act''.

SEC. 2. FINDINGS.

Congress makes the following findings:
(1) Iran voted in the United Nations General Assembly on
December 10, 1948, to adopt the Universal Declaration of Human
Rights, thereby committing to guarantee the ''life, liberty,
and security of person'' of all people and rejecting ''cruel,
inhuman, or degrading treatment or punishment''.
(2) The Constitution of the Islamic Republic of Iran
guarantees certain human rights and fundamental freedoms,
including political and civil rights, along with economic,
social, and cultural rights, including a prohibition on torture
and a guarantee of sentencing according to the law.
(3) The Islamic Republic of Iran is a party to 4 major
United Nations human rights treaties: the Convention on the
Rights of the Child (which it ratified on July 13, 1994), the
International Convention on the Elimination of All Forms of
Racial Discrimination (which it ratified on August 29, 1968),
and the International Covenant on Civil and Political Rights
and the International Covenant on Economic, Social and Cultural
Rights (both of which it ratified on June 24, 1975).
(4) The Government of the Islamic Republic of Iran is
violating its international and constitutional obligations to
respect the human rights and fundamental freedoms of its
citizens, including by--
(A) using torture and cruel, inhuman, or degrading
treatment or punishment, including flogging, and
amputations;
(B) carrying out an increasingly high rate of
executions in the absence of internationally recognized
safeguards, including public executions and executions
of juvenile offenders;
(C) using stoning as a method of execution and
maintaining a high number of persons in prison who
continue to face sentences of execution by stoning;
(D) carrying out arrests, violent repression, and
sentencing of women exercising their right to peaceful
assembly, a campaign of intimidation against women's
rights defenders, and continuing discrimination against
women and girls;
(E) permitting or carrying out increasing
discrimination and other human rights violations
against persons belonging to religious, ethnic,
linguistic, or other minorities;
(F) imposing ongoing, systematic, and serious
restrictions of freedom of peaceful assembly and
association and freedom of opinion and expression,
including the continuing closures of media outlets,
arrests of journalists, and the censorship of
expression in online forums such as blogs and websites;
and
(G) imposing severe limitations and restrictions on
freedom of religion and belief, including by carrying
out arbitrary arrests, indefinite detentions, and
lengthy jail sentences for those exercising their
rights to freedom of religion or belief and proposing a
provision in a draft penal code that sets out a
mandatory death sentence for apostasy, the abandoning
of one's faith.
(5) On June 19, 2009, the United Nations High Commissioner
for Human Rights expressed concerns about the increasing number
of arrests not in conformity with the law and the illegal use
of excessive force in responding to protests following the June
12, 2009, elections in Iran, resulting in at least dozens of
deaths and hundreds of injuries.
(6) On August 1, 2009, authorities in the Islamic Republic
of Iran began a mass trial of more than 100 individuals in
connection with election protests, most of whom were held for
weeks, in solitary confinement, with little or no access to
their lawyers or families, and many of whom showed signs of
torture or abuse.
(7) The Supreme Leader of Iran issued a statement on
October 28, 2009, effectively criminalizing dissent in the
aftermath of the national election of June 12, 2009.
(8) On November 4, 2009, security forces in the Islamic
Republic of Iran used brutal force to disperse thousands of
protesters, resulting in a number of injuries and arrests, in
violation of international standards regarding the
proportionate use of force against peaceful demonstrations.
(9) At least 8 citizens of Iran were killed and an
undetermined number were injured on December 27, 2009, when
security forces of the Islamic Republic of Iran violently broke
up peaceful gatherings during the Ashura holiday.
(10) The Government of the Islamic Republic of Iran has
recently sentenced numerous Iranian citizens to death without
due process for politicized crimes relating to the peaceful
demonstrations that followed the June 12, 2009, elections,
including ''waging war against God'', and has begun carrying
out those execution sentences, including the death by hanging
of 2 individuals on January 28, 2010.

SEC. 3. IMPOSITION OF SANCTIONS ON CERTAIN PERSONS WHO ARE COMPLICIT IN
HUMAN RIGHTS ABUSES COMMITTED AGAINST CITIZENS OF IRAN OR
THEIR FAMILY MEMBERS AFTER THE JUNE 12, 2009, ELECTIONS
IN IRAN.

(a) In General.--Except as provided in subsections (d) and (e), the
President shall impose sanctions described in subsection (c) with
respect to each person on the list required by subsection (b).
(b) List of Persons Who Are Complicit in Certain Human Rights
Abuses.--
(1) In general.--Not later than 90 days after the date of
the enactment of this Act, the President shall submit to the
appropriate congressional committees a list of persons who are
citizens of Iran that the President determines are complicit in
human rights abuses committed against citizens of Iran or their
family members on or after June 12, 2009, regardless of whether
such abuses occurred in Iran.
(2) Updates of list.--The President shall submit to the
appropriate congressional committees an updated list under
paragraph (1) periodically and as new information becomes
available.
(3) Public availability.--The list required by paragraph
(1) shall be made available to the public and posted on the
websites of the Department of the Treasury and the Department
of State.
(4) Consideration of data from other countries and
nongovernmental organizations.--In preparing the list required
by paragraph (1), the President shall consider data already
obtained by other countries and nongovernmental organizations,
including organizations in Iran, that monitor the human rights
abuses of the Government of Iran.
(c) Sanctions Described.--The sanctions described in this
subsection are the following:
(1) Visa ban.--Ineligibility for a visa to enter the United
States.
(2) Financial sanctions.--Sanctions authorized under the
International Emergency Economic Powers Act (50 U.S.C. 1701 et
seq.), including blocking of property and restrictions or
prohibitions on financial transactions and the exportation and
importation of property.
(d) Exceptions To Comply With International Agreements.--The
President may, by regulation, authorize exceptions to the imposition of
sanctions under this section to permit the United States to comply with
the Agreement between the United Nations and the United States of
America regarding the Headquarters of the United Nations, signed June
26, 1947, and entered into force November 21, 1947, and other
applicable international agreements.
(e) Waiver.--The President may waive the requirement to impose or
maintain sanctions with respect to a person under subsection (a) or the
requirement to include a person on the list required by subsection (b)
if the President--
(1) determines that such a waiver is in the national
interest of the United States; and
(2) submits to the appropriate congressional committees a
report describing the reasons for the determination.
(f) Termination of Sanctions.--The provisions of this section shall
cease to have force and effect on the date on which the President
determines and certifies to the appropriate congressional committees
that the Government of Iran has--
(1) unconditionally released all political prisoners,
including the citizens of Iran detained in the aftermath of the
June 12, 2009, presidential election in Iran;
(2) ceased its practices of violence, unlawful detention,
torture, and abuse of citizens of Iran while engaging in
peaceful political activity; and
(3) conducted a transparent investigation into the
killings, arrest, and abuse of peaceful political activists in
Iran and prosecuted those responsible.
(g) Appropriate Congressional Committees Defined.--In this section,
the term ''appropriate congressional committees'' has the meaning given
that term in section 14(2) of the Iran Sanctions Act of 1996 (Public
Law 104-172; 50 U.S.C. 1701 note).
[A]:
Iran Human Rights Sanctions Act - Directs the President to impose visa entry and financial sanctions on a person determined to be complicit in human rights abuses committed against Iranian citizens or their family members on or after June 12, 2009, regardless of whether such abuses occurred in Iran.

Requires that: (1) the list of such persons required by this Act be made available to the public and posted on the Department of the Treasury and the Department of State websites; and (2) the President consider data obtained by other countries and nongovernmental organizations that monitor Iran's human rights abuses in preparing such list.

Authorizes the President to: (1) not apply such sanctions in order to permit U.S. compliance with the Agreement between the United Nations and the United States of America regarding the Headquarters of the United Nations and other international agreements; and (2) waive such sanctions if in the U.S. national interest.

Terminates sanctions upon presidential certification to Congress that the government of Iran has: (1) released all political prisoners; (2) ceased its practices of violence and abuse of Iranian citizens engaging in peaceful political activity; and (3) conducted a transparent investigation into the killings and abuse of peaceful political activists in Iran and prosecuted those responsible.